½ÃÀ庸°í¼­
»óǰÄÚµå
1630984

¿ø°Ý ÀçȰ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ±¸¼º¿ä¼Òº°, ¼­ºñ½ºº°, Ä¡·á¹ýº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Telerehabilitation Market Size, Share & Trends Analysis Report By Component (Hardware, Software), By Services (Assessment, Therapy), By Therapy, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 100 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¿ø°Ý ÀçȰ ½ÃÀå ¼ºÀå°ú µ¿Çâ:

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ¼¼°è ¿ø°Ý ÀçȰ ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 118¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2030³â±îÁö 13.2%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿ø°Ý ÀçȰ »ê¾÷À» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÁÖ¿ä ¿äÀÎ Áß Çϳª´Â Àü ¼¼°èÀûÀ¸·Î ½º¸¶Æ®Æù°ú ÀÎÅͳÝÀÇ »ç¿ë È®´ë·Î ÀÎÇØ ÇコÄÉ¾î ºÐ¾ß¿¡¼­ µðÁöÅÐ ±â¼úÀÇ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù.

¿îµ¿ ±â´É, ½Å°æ ±â´É, °¨°¢ ±â´É µî À̵¿¿¡ ¹®Á¦°¡ Àִ ȯÀÚµéÀº ¿ø°Ý ÀçȰ ¼­ºñ½ºÀÇ ÇýÅÃÀ» ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. ³ªÀ̰¡ µé¼ö·Ï ¸¸¼ºÁúȯ°ú »ý¸®Àû ±â´É Àå¾Ö°¡ ¹ß»ýÇϱ⠽±½À´Ï´Ù. ÀÌ´Â ¾çÁúÀÇ ÀÇ·á Áö¿øÀÇ Çʿ伺À» ´õ¿í °­Á¶ÇÕ´Ï´Ù. ¿ø°Ý ÀçȰÀº ½Å¼ÓÇÑ Ä¡·á¸¦ °¡´ÉÇÏ°Ô Çϰí, °Åµ¿ÀÌ ºÒÆíÇØ ÀçȰ ¼­ºñ½º¸¦ ¹Þ±â ¾î·Á¿î ³ë³âÃþÀÌ º¸´Ù ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¼­ºñ½º°¡ µÉ ¼ö ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é, 2025³â±îÁö 60¼¼ ÀÌ»ó °í·ÉÀÚ´Â ¾à 12¾ï ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2050³â±îÁö 20¾ï ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î Àü¸ÁÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °í·ÉÈ­ »çȸ¿Í ¸¸¼ºÁúȯ ȯÀÚµéÀº ½ÃÀå ¼ö¿ä¸¦ Áõ°¡½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

COVID-19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇÑ Á¦ÇÑ, ºÒÇÊ¿äÇÑ Ä¡·áÀÇ ¿¬±â, ȯÀÚ Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇÑ º´µ¿ÀÇ COVID º´µ¿ ÀüȯÀ¸·Î ÀÎÇØ ¿ø°Ý ÀçȰ ¼­ºñ½º°¡ Å©°Ô Áõ°¡Çß½À´Ï´Ù. ¿¹¸¦ µé¾î, JCO Global Oncology-An American Society of Clinical Oncology Journal¿¡ °ÔÀçµÈ ¿¬±¸ ³í¹®¿¡ µû¸£¸é, COVID-19 ÆÒµ¥¹Í ±â°£ µ¿¾È °¨¿° È®»êÀ» ¸·±â À§ÇØ 2020³â¿¡ ¹°¸®Àû °Å¸®µÎ±â¸¦ À¯ÁöÇß½À´Ï´Ù. ±× °á°ú, ´ëºÎºÐÀÇ ¿Ü·¡ Á¾¾çÇÐ Áø·á´Â ¿ø°Ý ÀçȰÀ» ÅëÇØ ÀÌ·ç¾îÁ³½À´Ï´Ù.

¶ÇÇÑ, ½ÃÀå °­È­¸¦ À§ÇÑ ´Ù¾çÇÑ ³ë·ÂÀÌ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, NCBI(¹Ì±¹ »ý¸í°øÇÐ Á¤º¸ ¼¾ÅÍ)ÀÇ º¸°í¼­¿¡ µû¸£¸é ¾Æ¶ø ¿¡¹Ì¸®Æ®ÀÇ ¼ÎÀÌÅ© ÇÒ¸®ÆÄ ³úÁ¹Áß ¿¬±¸¼Ò´Â Á¸½º ȩŲ½º ÀÇÇÐ ¿¬±¸¼Ò¿Í Çù·ÂÇÏ¿© ¿ø°Ý ÀçȰ ŰƮ¸¦ °³¹ßÇϰí 2022³â ¸¶ÀÎµå ¸ð¼Ç GO ±â¼úÀ» ¿ÏÀüÈ÷ µµÀÔÇÏ´Â µ¥ µµ¿òÀ»ÁÖ°í ÀÖ½À´Ï´Ù.

¿ø°Ý ÀçȰ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • 2024³â¿¡´Â ¼ÒÇÁÆ®¿þ¾î ºÎ¹®ÀÌ °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È 13.5%ÀÇ CAGR·Î °¡Àå ºü¸¥ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ¸¹Àº ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀÌ ÀçÅà ÀçȰ ÇÁ·Î±×·¥À» À§ÇØ °³¹ßµÇ°í ÀÖÀ¸¸ç, ÀÌ´Â ÀÌ ºÐ¾ßÀÇ ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.
  • ÀÓ»ó Ä¡·á ºÐ¾ß´Â 2024³â °¡Àå Å« ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» Àå¾ÇÇßÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È 13.3%ÀÇ CAGR·Î °¡Àå ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀçȰ ¼­ºñ½º´Â Ä¡·á °á°ú¸¦ °³¼±ÇÏ¿© ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.
  • 2024³â¿¡´Â Àü ¼¼°èÀûÀ¸·Î Á¤Çü¿Ü°ú ¼ö¼úÀÌ Áõ°¡Çϰí Á¤Çü¿Ü°ú ÀÇ»çÀÇ ¿ø°Ý ÀçȰ ¼­ºñ½º äÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Á¤Çü¿Ü°ú ÀÀ¿ë ºÐ¾ß°¡ 31.9%ÀÇ ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù.
  • 2024³â ¹°¸®Ä¡·á´Â ´Ù¾çÇÑ ÀåÁ¡À¸·Î ÀÎÇØ ¼öÀÍÀÇ 43.0%¸¦ Â÷ÁöÇß½À´Ï´Ù. ȯÀÚ »óÅ¿¡ ¸Â´Â °³º° ÇÁ·Î±×·¥À» Á¦°øÇϰí, À̵¿ ºñ¿ë°ú ½Ã°£ÀÌ µéÁö ¾Ê¾Æ Æí¸®ÇÕ´Ï´Ù.
  • 2024³â ºÏ¹Ì´Â ÀÇ·á ÀÎÇÁ¶óÀÇ ¹ß´Þ, ¸¸¼ºÁúȯ À¯º´·ü Áõ°¡, ¿ø°Ý ÀçȰ ¼­ºñ½º µµÀÔÀ» ÃËÁøÇϱâ À§ÇÑ ´Ù¾çÇÑ ³ë·ÂÀ¸·Î ÀÎÇØ ¸ÅÃâÀÇ 41.5%¸¦ Â÷ÁöÇß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¿ø°Ý ÀçȰ ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • »óºÎ ½ÃÀå Àü¸Á
    • º¸Á¶ ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ¿ø°Ý ÀçȰ : ½ÃÀå ºÐ¼® Åø
    • ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTLE ºÐ¼®

Á¦4Àå ¿ø°Ý ÀçȰ ½ÃÀå ºÎ¹® ºÐ¼®, ±¸¼º¿ä¼Òº°, 2018-2030³â(¹é¸¸ ´Þ·¯)

  • Á¤ÀÇ¿Í ¹üÀ§
  • ÄÄÆ÷³ÍÆ® ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â¡¤2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ¿ø°Ý ÀçȰ ½ÃÀå, ±¸¼º¿ä¼Òº°, 2018-2030³â
  • Çϵå¿þ¾î
    • Çϵå¿þ¾î ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • ¼ÒÇÁÆ®¿þ¾î
    • ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â

Á¦5Àå ¿ø°Ý ÀçȰ ½ÃÀå ºÎ¹® ºÐ¼®, ¼­ºñ½ºº°, 2018-2030³â(¹é¸¸ ´Þ·¯)

  • Á¤ÀÇ¿Í ¹üÀ§
  • ¼­ºñ½º ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â¡¤2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ¿ø°Ý ÀçȰ ½ÃÀå, ¼­ºñ½ºº°, 2018-2030³â
  • ÀÓ»ó Æò°¡
    • ÀÓ»ó Æò°¡ ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • ÀÓ»ó Ä¡·á
    • ÀÓ»ó Ä¡·á ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â

Á¦6Àå ¿ø°Ý ÀçȰ ½ÃÀå ºÎ¹® ºÐ¼®, Ä¡·á¹ýº°, 2018-2030³â(¹é¸¸ ´Þ·¯)

  • Á¤ÀÇ¿Í ¹üÀ§
  • Ä¡·á¹ý ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â¡¤2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ¿ø°Ý ÀçȰ ½ÃÀå, Ä¡·á¹ýº°, 2018-2030³â
  • ¹°¸®Ä¡·á
    • ¹°¸®Ä¡·á ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • ÀÛ¾÷Ä¡·á
    • ÀÛ¾÷Ä¡·á ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • ±âŸ
    • ±âŸ ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â

Á¦7Àå ¿ø°Ý ÀçȰ ½ÃÀå ºÎ¹® ºÐ¼®, ¿ëµµº°, 2018-2030³â(¹é¸¸ ´Þ·¯)

  • Á¤ÀÇ¿Í ¹üÀ§
  • ¿ëµµ ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â¡¤2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ¿ø°Ý ÀçȰ ½ÃÀå, ¿ëµµº°, 2018-2030³â
  • ½ÉÇ÷°ü
    • ½ÉÇ÷°ü ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • Á¤Çü¿Ü°ú
    • Á¤Çü¿Ü°ú ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • ½Å°æÇÐ
    • ½Å°æÇÐ ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • ¼Ò¾Æ°ú
    • ¼Ò¾Æ°ú ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • ±âŸ
    • ±âŸ ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â

Á¦8Àå ¿ø°Ý ÀçȰ ½ÃÀå ºÎ¹® ºÐ¼®, ÃÖÁ¾ ¿ëµµº°, 2018-2030³â(¹é¸¸ ´Þ·¯)

  • Á¤ÀÇ¿Í ¹üÀ§
  • ÃÖÁ¾ ¿ëµµ ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â¡¤2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ¿ø°Ý ÀçȰ ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2018-2030³â
  • ÇコÄÉ¾î ½Ã¼³
    • ÇコÄÉ¾î ½Ã¼³ ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
  • ÀçÅà ÄÉ¾î ½Ã¼³
    • ÀçÅà ÄÉ¾î ½Ã¼³ ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â

Á¦9Àå ¿ø°Ý ÀçȰ ½ÃÀå ºÎ¹® ºÐ¼®, Áö¿ªº°, 2018-2030³â(¹é¸¸ ´Þ·¯)

  • Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â¡¤2030³â
  • Áö¿ª ½ÃÀå ´ë½Ãº¸µå
  • Áö¿ª ½ÃÀå ÇöȲ
  • ¿ø°Ý ÀçȰ ½ÃÀå Á¡À¯À² : Áö¿ªº°, 2024³â¡¤2030³â :
  • ºÏ¹Ì
    • ºÏ¹ÌÀÇ ¿ø°Ý ÀçȰ ½ÃÀå, 2018-2030³â
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • À¯·´ÀÇ ¿ø°Ý ÀçȰ ½ÃÀå, 2018-2030³â
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³ë¸£¿þÀÌ
    • ½º¿þµ§
    • µ§¸¶Å©
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • Äí¿þÀÌÆ®

Á¦10Àå °æÀï ±¸µµ

  • ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м®, ÁÖ¿ä ½ÃÀå ÁøÃâ ±â¾÷º°
  • ±â¾÷ ºÐ·ù
  • ±â¾÷ °³¿ä
    • American Well
    • Doctor On Demand, Inc.
    • Koninklijke Philips NV
    • Hinge Health, Inc.
    • Cisco Systems, Inc.
    • NeoRehab
    • C3O TelemedicineTM
    • Bosch Healthcare Solutions GmbH
    • Physio Cloud Software
    • Ludica Health Inc.(Jintronix.com)
ksm 25.02.03

Telerehabilitation Market Growth & Trends:

The global telerehabilitation market size is estimated to reach USD 11.81 billion by 2030, registering to grow at a CAGR of 13.2% from 2025 to 2030 according to a new report by Grand View Research, Inc. One of the main factors anticipated to propel the telerehabilitation industry is the increasing usage of digital technologies in the healthcare sector owing to the expanding use of smartphones and the internet globally.

Patients with mobility problems, such as those with motor, neurological, and sensory functions, can benefit from telerehabilitation services. People become increasingly susceptible to chronic disease and physiological dysfunction as they get older. This further emphasizes the need for high-quality medical assistance. Telerehabilitation facilitates fast treatments and makes services more accessible for the elderly population, who find it challenging to get rehabilitation services due to mobility issues. As per the World Health Organization, there will be approximately 1.2 billion individuals over the age of 60 by 2025, and this number is anticipated to raise to 2.0 billion by 2050. Additionally, it is projected that the aging population and those with chronic illnesses will boost the market demand.

Due to the COVID-19 pandemic's restrictions, postponement of non-essential treatments, and transformation of wards into COVID wards to address the increasing number of patients, the telerehabilitation services witnessed a considerable increase. For instance, as per a research article that was published in JCO Global Oncology-An American Society of Clinical Oncology Journal, 2020 physical distance was maintained during the COVID-19 pandemic to reduce the spread of the disease. As a result, telerehabilitation was used for most outpatient oncology appointments.

Further, various initiatives undertaken to strengthen the market is impelling the growth. For instance, according to a report by the NCBI (National Center for Biotechnology Information), the Sheikh Khalifa Stroke Institute in the United Arab Emirates collaborated with Johns Hopkins Medicine to support the development of telerehabilitation kits and the full implementation of the Mind Motion GO technology in 2022.

Telerehabilitation Market Report Highlights:

  • The software segment dominated the market with the largest revenue share in 2024 and is anticipated to witness the fastest growth with a CAGR of 13.5% over the forecast period. Also, many software solutions are developed to address home-based rehabilitation programs, which is adding fuel to the segment growth
  • The clinical therapy segment dominated the market with the largest revenue share in 2024 and is anticipated to witness the fastest growth with a CAGR of 13.3% over the forecast period. The rehabilitation services have resulted in improved outcomes, which is positively impacting the market growth
  • In 2024, orthopedic application segment dominated the market with a revenue share of 31.9% owing to rising orthopedic surgeries across the globe and increasing adoption of telerehabilitation services by orthopedic surgeons
  • In 2024, physical therapy accounted for 43.0% of the revenue owing to its various benefits. It provides a personalized program for the patient's condition and is convenient with no travel costs and time
  • In 2024, North America accounted for 41.5% of the revenue due to well-developed healthcare infrastructure, increased prevalence of chronic diseases, and various initiatives were undertaken to promote the adoption of telerehabilitation services

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Component outlook
    • 2.2.2. Services outlook
    • 2.2.3. Therapy outlook
    • 2.2.4. Application outlook
    • 2.2.5. End Use outlook
    • 2.2.6. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Telerehabilitation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Telerehabilitation: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis

Chapter 4. Telerehabilitation Market Segment Analysis, By Component, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Component Market Share Analysis, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Telerehabilitation Market, by Component, 2018 - 2030
  • 4.5. Hardware
    • 4.5.1. Hardware market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Software
    • 4.6.1. Software market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Telerehabilitation Market Segment Analysis, By Services, 2018 - 2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Services Market Share Analysis, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Telerehabilitation Market, by Services, 2018 - 2030
  • 5.5. Clinical Assessment
    • 5.5.1. Clinical Assessment market estimates and forecasts, 2018 - 2030 (USD million)
  • 5.6. Clinical Therapy
    • 5.6.1. Clinical Therapy market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Telerehabilitation Market Segment Analysis, By Therapy, 2018 - 2030 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. Therapy Market Share Analysis, 2024 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Telerehabilitation Market, by Therapy, 2018 - 2030
  • 6.5. Physical Therapy
    • 6.5.1. Physical Therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Occupational Therapy
    • 6.6.1. Occupational Therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Telerehabilitation Market Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 7.1. Definition and Scope
  • 7.2. Application Market Share Analysis, 2024 & 2030
  • 7.3. Segment Dashboard
  • 7.4. Global Telerehabilitation Market, by Application, 2018 - 2030
  • 7.5. Cardiovascular
    • 7.5.1. Cardiovascular market estimates and forecasts, 2018 - 2030 (USD million)
  • 7.6. Orthopedic
    • 7.6.1. Orthopedic market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7. Neurology
    • 7.7.1. Neurology market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8. Pediatric
    • 7.8.1. Pediatric market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.9. Others
    • 7.9.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Telerehabilitation Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 8.1. Definition and Scope
  • 8.2. End Use Market Share Analysis, 2024 & 2030
  • 8.3. Segment Dashboard
  • 8.4. Global Telerehabilitation Market, by End Use, 2018 - 2030
  • 8.5. Healthcare Facilities
    • 8.5.1. Healthcare Facilities market estimates and forecasts, 2018 - 2030 (USD million)
  • 8.6. Homecare Setting
    • 8.6.1. Homecare Setting market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Telerehabilitation Market Segment Analysis, By Region, 2018- 2030 (USD Million)

  • 9.1. Regional Market Share Analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Regional Market Snapshot
  • 9.4. Telerehabilitation Market Share by Region, 2024 & 2030:
  • 9.5. North America
    • 9.5.1. North America telerehabilitation market, 2018 - 2030 (USD Million)
    • 9.5.2. U.S.
      • 9.5.2.1. U.S. telerehabilitation market, 2018 - 2030 (USD Million)
    • 9.5.3. Canada
      • 9.5.3.1. Canada telerehabilitation market, 2018 - 2030 (USD Million)
    • 9.5.4. Mexico
      • 9.5.4.1. Mexico telerehabilitation market, 2018 - 2030 (USD Million)
  • 9.6. Europe
    • 9.6.1. Europe telerehabilitation market, 2018 - 2030 (USD Million)
    • 9.6.2. UK
      • 9.6.2.1. UK telerehabilitation market, 2018 - 2030 (USD Million)
    • 9.6.3. Germany
      • 9.6.3.1. Germany telerehabilitation market, 2018 - 2030 (USD Million)
    • 9.6.4. France
      • 9.6.4.1. France telerehabilitation market, 2018 - 2030 (USD Million)
    • 9.6.5. Italy
      • 9.6.5.1. Italy telerehabilitation market, 2018 - 2030 (USD Million)
    • 9.6.6. Spain
      • 9.6.6.1. Spain telerehabilitation market, 2018 - 2030 (USD Million)
    • 9.6.7. Norway
      • 9.6.7.1. Norway telerehabilitation market, 2018 - 2030 (USD Million)
    • 9.6.8. Sweden
      • 9.6.8.1. Sweden telerehabilitation market, 2018 - 2030 (USD Million)
    • 9.6.9. Denmark
      • 9.6.9.1. Denmark telerehabilitation market, 2018 - 2030 (USD Million)
  • 9.7. Asia Pacific
    • 9.7.1. Japan
      • 9.7.1.1. Japan telerehabilitation market, 2018 - 2030 (USD Million)
    • 9.7.2. China
      • 9.7.2.1. China telerehabilitation market, 2018 - 2030 (USD Million)
    • 9.7.3. India
      • 9.7.3.1. India telerehabilitation market, 2018 - 2030 (USD Million)
    • 9.7.4. Australia
      • 9.7.4.1. Australia telerehabilitation market, 2018 - 2030 (USD Million)
    • 9.7.5. South Korea
      • 9.7.5.1. South Korea telerehabilitation market, 2018 - 2030 (USD Million)
    • 9.7.6. Thailand
      • 9.7.6.1. Thailand telerehabilitation market, 2018 - 2030 (USD Million)
  • 9.8. Latin America
    • 9.8.1. Brazil
      • 9.8.1.1. Brazil telerehabilitation market, 2018 - 2030 (USD Million)
    • 9.8.2. Argentina
      • 9.8.2.1. Argentina telerehabilitation market, 2018 - 2030 (USD Million)
  • 9.9. MEA
    • 9.9.1. South Africa
      • 9.9.1.1. South Africa telerehabilitation market, 2018 - 2030 (USD Million)
    • 9.9.2. Saudi Arabia
      • 9.9.2.1. Saudi Arabia telerehabilitation market, 2018 - 2030 (USD Million)
    • 9.9.3. UAE
      • 9.9.3.1. UAE telerehabilitation market, 2018 - 2030 (USD Million)
    • 9.9.4. Kuwait
      • 9.9.4.1. Kuwait telerehabilitation market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Company Profiles
    • 10.3.1. American Well
      • 10.3.1.1. Company overview
      • 10.3.1.2. Financial performance
      • 10.3.1.3. Product benchmarking
      • 10.3.1.4. Strategic initiatives
    • 10.3.2. Doctor On Demand, Inc.
      • 10.3.2.1. Company overview
      • 10.3.2.2. Financial performance
      • 10.3.2.3. Product benchmarking
      • 10.3.2.4. Strategic initiatives
    • 10.3.3. Koninklijke Philips N.V.
      • 10.3.3.1. Company overview
      • 10.3.3.2. Financial performance
      • 10.3.3.3. Product benchmarking
      • 10.3.3.4. Strategic initiatives
    • 10.3.4. Hinge Health, Inc.
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Product benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. Cisco Systems, Inc.
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Product benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. NeoRehab
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Product benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. C3O TelemedicineTM
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Product benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. Bosch Healthcare Solutions GmbH
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Product benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. Physio Cloud Software
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Product benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. Ludica Health Inc. (Jintronix.com)
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Product benchmarking
      • 10.3.10.4. Strategic initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦